- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.05
7D
-7.5%
1Y
11.0%
Eupraxia Pharmaceuticals
Market Cap: CA$640.2m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.46
7D
-0.7%
1Y
24.0%
Verano Holdings
Market Cap: CA$610.7m
Engages in the cannabis business in the United States.
VRNO
CA$8.38
7D
-7.7%
1Y
92.6%
Cresco Labs
Market Cap: CA$490.5m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.08
7D
-6.9%
1Y
18.7%
Spectral Medical
Market Cap: CA$393.2m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.35
7D
1.5%
1Y
58.8%
TerrAscend
Market Cap: CA$302.2m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.81
7D
-11.0%
1Y
52.8%
High Tide
Market Cap: CA$276.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.12
7D
-4.0%
1Y
-3.4%
Aurora Cannabis
Market Cap: CA$237.2m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$3.86
7D
-5.6%
1Y
-37.0%
Organigram Global
Market Cap: CA$198.5m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.37
7D
-5.5%
1Y
-30.8%
Cardiol Therapeutics
Market Cap: CA$168.3m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.44
7D
-5.9%
1Y
-20.0%
HLS Therapeutics
Market Cap: CA$133.9m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.31
7D
2.6%
1Y
-11.3%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
-4.3%
1Y
29.4%
Planet 13 Holdings
Market Cap: CA$60.4m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.18
7D
-7.7%
1Y
-35.7%
Vext Science
Market Cap: CA$55.7m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.23
7D
2.2%
1Y
35.3%
Sernova Biotherapeutics
Market Cap: CA$49.1m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.13
7D
-3.8%
1Y
-24.2%
Optimi Health
Market Cap: CA$37.0m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.49
7D
-9.2%
1Y
39.6%
Medicenna Therapeutics
Market Cap: CA$34.6m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.37
7D
-6.3%
1Y
-56.0%
Rubicon Organics
Market Cap: CA$30.1m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
-1.1%
1Y
-6.3%
Delivra Health Brands
Market Cap: CA$3.3m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
-4.5%
1Y
-56.3%